Keata buys Pfizer's Canadian facility
PharmEng's subsidiary Keata Pharma is the new owner of Pfizer's manufacturing facility in Arnprior, Canada, which the drug giant has been trying to pass on for over a year.
PharmEng's subsidiary Keata Pharma is the new owner of Pfizer's manufacturing facility in Arnprior, Canada, which the drug giant has been trying to pass on for over a year.
Consort Medical, Quintiles, Covance and PPD have all had people on the move in the world of pharmaceutical outsourcing.
US researchers have developed a new biochip technology that could dramatically reduce the need for animal testing during drug development safety studies.
Annual round up of all drugs entering Phase I
DrugResearcher.com brings you its annual round up of all the drugs that entered clinical development in 2007.
France-based Flamel Technologies and Merck Serono have shook hands on a new €2m ($2.9m) deal which would see Flamel's Medusa technology used to develop an extended-release profile of an undisclosed therapeutic protein.
Enzo Life Sciences has signed a letter of intent to acquire Belgian life science tools distributor 10P's BVBA for an undisclosed amount.
Outsourcing-Pharma.com compiles the news that has featured in the clinical contract community of late, involving PPD, PRA, Accutest and Premier Research.